298 related articles for article (PubMed ID: 30471715)
21. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase.
Parad RB; Allred EN; Rosenfeld WN; Davis JM
Neonatology; 2012; 102(2):139-44. PubMed ID: 22710821
[TBL] [Abstract][Full Text] [Related]
22. Vitamin E and preterm infants.
Ogihara T; Mino M
Free Radic Biol Med; 2022 Feb; 180():13-32. PubMed ID: 34871765
[TBL] [Abstract][Full Text] [Related]
23. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.
Regan FM; Williams RM; McDonald A; Umpleby AM; Acerini CL; O'Rahilly S; Hovorka R; Semple RK; Dunger DB
J Clin Endocrinol Metab; 2010 May; 95(5):2113-22. PubMed ID: 20233784
[TBL] [Abstract][Full Text] [Related]
24. Cohort study of growth patterns by gestational age in preterm infants developing morbidity.
Klevebro S; Lundgren P; Hammar U; Smith LE; Bottai M; Domellöf M; Löfqvist C; Hallberg B; Hellström A
BMJ Open; 2016 Nov; 6(11):e012872. PubMed ID: 27856479
[TBL] [Abstract][Full Text] [Related]
25. rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia.
Seedorf G; Kim C; Wallace B; Mandell EW; Nowlin T; Shepherd D; Abman SH
Am J Respir Crit Care Med; 2020 May; 201(9):1120-1134. PubMed ID: 32101461
[No Abstract] [Full Text] [Related]
26. [The morbidities of extremely preterm and extremely low birth weight infants during hospitalization].
;
Zhonghua Er Ke Za Zhi; 2015 May; 53(5):334-40. PubMed ID: 26080662
[TBL] [Abstract][Full Text] [Related]
27. Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.
Heatwole CR; Eichinger KJ; Friedman DI; Hilbert JE; Jackson CE; Logigian EL; Martens WB; McDermott MP; Pandya SK; Quinn C; Smirnow AM; Thornton CA; Moxley RT
Arch Neurol; 2011 Jan; 68(1):37-44. PubMed ID: 20837825
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
29. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD;
JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753
[TBL] [Abstract][Full Text] [Related]
30. Effect of a Novel Oxygen Saturation Targeting Strategy on Mortality, Retinopathy of Prematurity, and Bronchopulmonary Dysplasia in Neonates Born Extremely Preterm.
Srivatsa B; Malcolm K; Clark RH; Kupke KG
J Pediatr; 2021 Jul; 234():33-37.e3. PubMed ID: 33737029
[TBL] [Abstract][Full Text] [Related]
31. IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.
Hellstrom A; Ley D; Hallberg B; Lofqvist C; Hansen-Pupp I; Ramenghi LA; Borg J; Smith LEH; Hard AL
Curr Pharm Des; 2017; 23(38):5964-5970. PubMed ID: 28969546
[TBL] [Abstract][Full Text] [Related]
32. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.
Suresh GK; Davis JM; Soll RF
Cochrane Database Syst Rev; 2001; 2001(1):CD001968. PubMed ID: 11279743
[TBL] [Abstract][Full Text] [Related]
33. Retinopathy of prematurity and serum level of insulin-like growth factor-1.
Banjac L; Bokan V
Acta Clin Croat; 2012 Jun; 51(2):209-13. PubMed ID: 23115944
[TBL] [Abstract][Full Text] [Related]
34. Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: A cohort study.
Kermorvant-Duchemin E; Le Meur G; Plaisant F; Marchand-Martin L; Flamant C; Porcher R; Lapillonne A; Chemtob S; Claris O; Ancel PY; Rozé JC
PLoS Med; 2020 Dec; 17(12):e1003477. PubMed ID: 33306685
[TBL] [Abstract][Full Text] [Related]
35. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.
Kapoor V; Glover R; Malviya MN
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009172. PubMed ID: 26630252
[TBL] [Abstract][Full Text] [Related]
36. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
37. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
[TBL] [Abstract][Full Text] [Related]
38. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
Bell EF; Hintz SR; Hansen NI; Bann CM; Wyckoff MH; DeMauro SB; Walsh MC; Vohr BR; Stoll BJ; Carlo WA; Van Meurs KP; Rysavy MA; Patel RM; Merhar SL; Sánchez PJ; Laptook AR; Hibbs AM; Cotten CM; D'Angio CT; Winter S; Fuller J; Das A;
JAMA; 2022 Jan; 327(3):248-263. PubMed ID: 35040888
[TBL] [Abstract][Full Text] [Related]
39. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
40. BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely low gestational age neonates.
Teofili L; Papacci P; Orlando N; Bianchi M; Pasciuto T; Mozzetta I; Palluzzi F; Giacò L; Giannantonio C; Remaschi G; Santosuosso M; Beccastrini E; Fabbri M; Valentini CG; Bonfini T; Cloclite E; Accorsi P; Dragonetti A; Cresi F; Ansaldi G; Raffaeli G; Villa S; Pucci G; Mondello I; Santodirocco M; Ghirardello S; Vento G
Trials; 2022 Dec; 23(1):1010. PubMed ID: 36514106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
